RBC Capital analyst Arun Viswanathan raised the firm’s price target on Linde (LIN) to $552 from $512 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Specialty Chemicals names. The firm continues to see company-specific items as major drivers for improvement in 2026, with a preference for names with minimal impact from Middle East conflict and higher oil cost, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIN:
